# FDA Inspection 1306856 - AbbVie Inc. - March 03, 2026

Source: https://www.keypedia.com/records/fda_inspections/abbvie-inc/c6dbe258-505c-420c-8d90-e296d9fdc4b3
Source feed: FDA_Inspections

> FDA Inspection 1306856 for AbbVie Inc. on March 03, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1306856
- Company Name: AbbVie Inc.
- Inspection Date: 2026-03-03
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs

## Related Documents

- [FDA Inspection 1306856 - 2026-03-03](https://www.keypedia.com/records/fda_inspections/abbvie-inc/93209412-814d-4a62-8488-c4c7f9580e77)
- [FDA Inspection 1243191 - 2024-06-18](https://www.keypedia.com/records/fda_inspections/abbvie-inc/fc0238a4-9a84-4d4c-9827-fdf81f844c14)
- [FDA Inspection 1070526 - 2018-08-24](https://www.keypedia.com/records/fda_inspections/abbvie-inc/290a9727-9150-4dd7-acdc-6bf823eb94bd)
- [FDA Inspection 1070526 - 2018-08-24](https://www.keypedia.com/records/fda_inspections/abbvie-inc/7c867145-16df-444b-8eb2-0ee11ae4237f)
- [FDA Inspection 934438 - 2015-08-06](https://www.keypedia.com/records/fda_inspections/abbvie-inc/e003e4e6-9bd9-484a-8dd1-baa468c97ea6)

Company: https://www.keypedia.com/companies/abbvie-inc/404ebab5-56a6-486d-bb01-be43a9478fad